Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Current Topics in Medicinal Chemistry|January 16, 2018
Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s DiseaseLhassane Ismaili, Maria do Carmo Carreiras
Expert Opinion on Drug Discovery|October 6, 2023
Calcium channel blockers' contribution to overcoming Current drug discovery challenges in Alzheimer's diseasePaul J Bernard, Djamila Bellili, Lhassane Ismaili
Molecules (Basel, Switzerland)|May 14, 2025
Nrf2 Activation and Antioxidant Properties of Chromone-Containing MTDLs for Alzheimer's Disease TreatmentAlexey Simakov, Stecy Chhor, Lhassane Ismaili, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2019
Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapyMaria do Carmo Carreiras, Lhassane Ismaili, José Marco-Contelles
Future Medicinal Chemistry|October 20, 2022
Multicomponent reactions as a privileged tool for multitarget-directed ligand strategies in Alzheimer's disease therapySylvain Grosjean, Irene Pachón-Angona, Michella Dawra, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 19, 2005
Huperzine A--human serum albumin association: chromatographic and thermodynamic approachFrançois Darrouzain, Claire André, Lhassane Ismaili, et al.
International Journal of Medicinal Chemistry|May 9, 2015
Pharmacophore modelling and synthesis of quinoline-3-carbohydrazide as antioxidantsMustapha El Bakkali, Lhassane Ismaili, Isabelle Tomassoli, et al.
Talanta|December 17, 2008
A novel cyclic hexapeptide as chiral selector: Application for HPLC separation of a series of dansyl amino and arylalkanoic acidsClaire André, Mireille Thomassin, Arunalyat Umrayami, et al.
Future Medicinal Chemistry|August 17, 2021
Synthesis of new Hantzsch adducts showing Ca2+ channel blockade capacity, cholinesterase inhibition and antioxidant powerIrene Pachón-Angona, Maciej Maj, Artur Wnorowski, et al.
Pageof 6